ea0049ep465 | Diabetes (to include epidemiology, pathophysiology) | ECE2017
Nurrulina Guzel
, Valeeva Farida
, Khasanova Kamilya
Introduction: Glucocorticoid therapy (GCT) is one of the risk factors of carbohydrate metabolism disorders (CMD) in patents with systemic inflammatory diseases. CMD development is a concern not only with long-term therapy, but also during intensive short-term glucocorticoid (GC) administration, which can lead to different CMDs, including impaired glucose tolerance (IGT) and diabetes mellitus (DM).Aim: To evaluate the prevalence of CMD after long-term and...